Search for: "MERCK " Results 201 - 220 of 3,321
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2021, 12:49 am by Rose Hughes
The Finnish firm representing Merck report that the matter has thus been referred to the CJEU. [read post]
7 Dec 2021, 2:01 am by Jen Patja Howell
Julie Gerberding, who served as director of the Centers for Disease Control and Prevention from 2002 to 2009 and now is a senior leader at the pharmaceutical company Merck; and Matt Berrett, a former CIA assistant director and head of its Global Issues Mission Center, and now cofounder of the Center for Anticipatory Intelligence at Utah State University. [read post]
23 Nov 2021, 5:26 pm by Sabrina I. Pacifici
The FDA will decide on Nov. 30 if Merck will get an emergency use authorization for a COVID pill called molnupiravir. [read post]
19 Nov 2021, 10:46 am by Rebecca Tushnet
Neurelis argued that the exemption to the anti-SLAPP law was specifically focused on overturning DuPont Merck Pharmaceutical Co. v. [read post]
7 Nov 2021, 6:00 pm by Juvan Bonni
Recent Headlines in the IP World: Blake Brittain: Senators Slam Albright Over ‘Extreme Concentration’ of Patent Cases (Source: Reuters) Smart & Biggar: Supreme Court of Canada Denies Leave Regarding Lisdexamfetamine Patent Decision (Source: JD Supra) Blake Brittain: Week Ahead in Intellectual Property: Nov. 1, 2021 (Source: Reuters) Stephanie Nolen: Merck Will Share Formula for Its Covid Pill With Poor Countries (Source: The New York Times) Ali Jones:… [read post]
5 Nov 2021, 9:27 am by Tom Smith
That’s even higher than the 50% reduction in hospitalizations and deaths shown by the Merck pill. [read post]
5 Nov 2021, 8:20 am by Lisa Larrimore Ouellette
 After the animal study was published in April 2020, Merck also became interested in the drug, and on May 26 Merck and Ridgeback announced a collaboration under which Ridgeback would continue to sponsor Phase 1 and 2 trials and manufacturing campaigns, after which Merck would lead the collaboration. [read post]
3 Nov 2021, 9:52 am by Tim De Chant
Yesterday, the court heard that Holmes did it once more, sending reports that prominently featured the logo of Schering-Plough, the large pharmaceutical company that was acquired by Merck in 2009. [read post]
31 Oct 2021, 9:20 pm by Patent Docs
Ashita Doshi of Thermo Fisher Scientific, Nichole Valeyko of Merck & Co., Ben Searle of HP Inc., and Todd Walters of Buchanan Ingersoll & Rooney PC will discuss strategies and practical tips for obtaining patent portfolios that survive post-grant attacks, including a discussion of the following topics: PTAB statistics, application drafting, claim drafting strategies, prosecution strategies, obtaining a robust portfolio, and knowing when and where to assert your... [read post]
29 Oct 2021, 10:32 am by Emily Dai
The drug costs about $4 for a 10-day course, relatively less expensive than Merck’s $700-per-course coronavirus pill. [read post]
20 Oct 2021, 4:25 pm by Holly Buckley
Co-investors joining Carlyle in the investment included Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners. [read post]
17 Oct 2021, 9:24 pm by Patent Docs
Ltd v Commissioner of Patents [2021] FCA 643, and Merck Sharp & Dohme Corp. v Sandoz Pty Ltd [2021] FCA 947. [read post]
15 Oct 2021, 4:00 am by Martin Kratz
Canadian Institute of Chartered Accountants, 2011 FC 1516, 2011 CarswellNat 5412 at para. 9; Merck & Co. at para. 24). [read post]
11 Oct 2021, 11:10 am by Emily Dai
The event will feature Peter Sands, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria; and Julie Gerberding, executive vice president and chief patient officer at Merck & Co., Inc. [read post]
11 Oct 2021, 11:06 am by Emily Dai
  Pharmaceutical company Merck is seeking U.S. [read post]
9 Oct 2021, 9:48 am by Juvan Bonni
Recent Headlines in the IP World: Ahmar Khan: Canada Lacks ‘Political Will’ to Waive COVID-19 Vaccine Patents, Bolivian Minister Says (Source: Global News) Andreas Curkovic: Psygen Announces That Psilocybin from Its Patent-Pending Process Has Been Used in Human Trial (Source: Yahoo Finance) Blake Brittain: Apple Loses (and Wins) Rulings in ‘Home Button’ Patent Dispute (Source: Reuters) Scott French: N2 Packaging Systems, LLC Expands its Global Patent Portfolio… [read post]
8 Oct 2021, 7:21 am by Tom Smith
”If you’re thinking it was only a matter of time before the mere fact of molnupiravir’s existence would be pitched in headlines as actual bad news, you’re not wrong: Marketwatch came out with “‘It’s not a magic pill’: What Merck’s antiviral pill could mean for vaccine hesitancy” the same day Merck issued its release. [read post]